Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-22T11:37:08.319Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacological Modification of Bradykinin Induced Breakdown of the Blood-brain Barrier

Published online by Cambridge University Press:  18 September 2015

Jennifer J. Raymond ,
David M. Robertson  and
Henry B. Dinsdale
Jennifer J. Raymond
Affiliation:
Departments of Pathology and Medicine, Queen's University and Kingston General Hospital, Kingston
David M. Robertson*
Affiliation:
Departments of Pathology and Medicine, Queen's University and Kingston General Hospital, Kingston
Henry B. Dinsdale
Affiliation:
Departments of Pathology and Medicine, Queen's University and Kingston General Hospital, Kingston
*
Department of Pathology, Queen's University, Kingston, Ontario, Canada K7L 3N6
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Internal carotid artery infusion of bradykinin caused extensive breakdown of the blood-brain barrier to protein as demonstrated by the extravasation of the marker, horseradish peroxidase, into vessel walls and the adjacent parenchyma. Pretreatment of the animals with indomethacin, trifluoperazine, or imidazole significantly reduced the quantity of abnormally permeable vessels as determined by light microscopy. By electron microscopy, it was determined that bradykinin caused an intense increase in the number of pinocytotic vesicles in the permeable segments, but no change in the interendothelial junctions. After imidazole pretreatment, although the extent of the permeability change was markedly reduced, the intensity of pinocytotic activity in the involved areas was not altered.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue 3 , August 1986 , pp. 214 - 220
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Hansson, HA, Johansson, BB.Blomstrand, C.Ultrastructural studies on cerebrovascular permeability in acute hypertension. Acta Neuropathol 1975:32: 187–198.CrossRefGoogle ScholarPubMed
2.Nag, S, Robertson, DM, Dinsdale, HB.Quantitative estimate of pinocytosis in experimental acute hypertension. Acta Neuropathol 1979:46: 107–116.CrossRefGoogle ScholarPubMed
3.Hansson, HA, Johansson, BB.Induction of pinocytosis in cerebral vessels by acute hypertension and by hyperosmolar solutions. J Neurosci Res 1980; 5: 183–190.CrossRefGoogle ScholarPubMed
4.Baker, RN, Cancilla, PA.Pollock, PS, et al. The movement of exogenous protein in experimental cerebral edema. An electron microscopic study after freeze injury. J Neuropathol Exp Neurol 1971; 30: 668–679.CrossRefGoogle ScholarPubMed
5.Mitchell, J, Weller, RO.Evans, H.Re-establishment of the bloodbrain barrier to peroxidase following cold injury to mouse cortex. Acta Neuropathol 1979; 46: 45–49.CrossRefGoogle Scholar
6.Johansson, BB.Pharmacological modification of hypertensive bloodbrain barrieropening. Acta Pharmacol Toxicol 1981:48:242–247.CrossRefGoogle Scholar
7.Raymond, JJ, Robertson, DM, Dinsdale, HBet al. Pharmacological modification of blood-brain barrier permeability following a cold lesion. Can J Neurol Sci 1984; 2: 447–451.CrossRefGoogle Scholar
8.Haddy, FJ, Emerson, TE Jr, Scott, JBet al. The effects of kinins on the cardiovascular system. In: Erdos, EG, ed. Handbook of experimental pharmacology. Bradykinin, Kalladinand Kallekrein. New York: Springer-Verlag 1970: 25: 362–384.Google Scholar
9.Perry, DC, Snyder, SH.Identification of bradykinin in mammalian brain. J Neurochem 1984:43: 1072–1080.CrossRefGoogle ScholarPubMed
10.Unterberg, A, Wahl, M, Baethmann, A.Effects of bradykinin on cerebrovascular permeability and resistance. J Cereb Blood Flow Metab 1983; 3 Suppl 1: S234–S235.Google Scholar
11.Lwata, T, Hashimoto, H, Hiwada, Ket al. Changes of plasma renin activity by intracerebroventricular administration of biological active peptides in conscious rats. Clin Exp Theory Practice 1984; A6: 1055–1066.Google Scholar
12.Lambert, GA, Lang, WJ.The effects of bradykinin and eledoisin injected into the cerebral ventricles of conscious rats. Eur J Pharmacol 1970; 9: 383–386.CrossRefGoogle ScholarPubMed
13.Lewis, RE, Phillips, MI.Localization of the central pressor action of bradykinin to the cerebral third ventricle. Am J Physiol 1984; 247: R63–R68.Google Scholar
14.Kontos, HA, Wei, EP, Povlishock, JTet al. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 1984; 55: 295–303.CrossRefGoogle ScholarPubMed
15.Unterberg, A, Baethmann, AJ.The kallikrein-kinin systemas mediator in vasogenic brain edema. Part I: Cerebral exposure to bradykinin and plasma. J Neurosurg 1984: 61: 87–96.CrossRefGoogle Scholar
16.Unterberg, A, Wahl, M, Baethmann, A.Effects of bradykinin on blood-brain barrier function and pial microcirculation. In: Jensen, HP, Brock, M.Klinger, M, eds. Advances in Neurosurgery. Berlin: Springer-Verlag 1983: 2: 355–358.Google Scholar
17.Toda, N.Actions of bradykinin on isolated cerebral and peripheral arteries. Am J Physiol 1977; 232: H267–H274.Google Scholar
18.Whally, ET, Wahl, M.The effect of kinase II inhibitors on the response of feline cerebral arteries to bradykinin and angiotensin. Pflugers Arch 1983; 398: 175–177.CrossRefGoogle Scholar
19.Graham, RC Jr, Karnovsky, MJ.The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 1966; 14: 291–302.CrossRefGoogle ScholarPubMed
20.Venable, JH, Coggeshall, R.A simplified lead citrate stain for use in electron microscopy. J Cell Biol 1965; 25: 407–410.CrossRefGoogle ScholarPubMed
21.Wahl, M.Young, AR, Edvinsson, Let al. Effects of bradykinin on pial arteries and arterioles in vitro and in situ. J Cerebral Blood Flow Metab 1983: 3: 231–237.CrossRefGoogle ScholarPubMed
22.Mcgiff, JC, Itskovitz, HD, Terragno, NA.The actions of bradykinin and eledoisin in the canine isolated kidney: relationships to prostaglandins. Clin Sci Mol Med 1975:49: 125–131.Google ScholarPubMed
23.Suzuki, M, Satoh, S.Suppression of bradykinin-induced renin release by indomethacin in anaesthetized rats. Clin and Exp Hypertension Theory and Prac 1984; A6: 1227–1235.CrossRefGoogle Scholar
24.Cherry, PD, Furchgott, RF, Zawadzki, JVet al. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982; 79: 2106–2110.CrossRefGoogle ScholarPubMed
25.Chand, N, Altura, BM.Endothelial cells and relaxation of vascular smooth muscle cells: possible relevance to lipoxygenesases and their significance in vascular diseases. Microcirculation 1981; 1: 297–317.Google Scholar
26.Vanhoutte, PM.Functional role ofthe endothelial cells. J Pharmacol 1983; 14: Suppl 3, 73–79.Google Scholar
27.Gawlowski, DM, Ritter, AB.Duran, WN.Reproducibility of microvascular permeability responses to successive topical applications of bradykinin in the hampster cheek pouch. Microvasc Res 1982: 24: 354–363.CrossRefGoogle Scholar
28.Abdel-Halim, MS, Sjoquist, B, Anggard, E.Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol Toxicol 1978:43:266–272.CrossRefGoogle ScholarPubMed
29.Mcculloch, J, Kelly, PAT.Grome, JJetal. Local cerebral circulatory and metabolic effects of indomethacin. Am J Physiol 1982; 243: H416–H423.Google ScholarPubMed
30.Seaman, KB, Daly, JW.Calmodulin stimulation of adenylate cyclase in rat brain membranes does not require GTP. Life Sci 1982; 30: 1457–1464.CrossRefGoogle Scholar
31.Lichtman, AH, Segei, GB, Lichtman, MA.Effects of Trifluoperazine and mitogenic lectins on calcium ATPase activity and calcium transport by human lymphocyte plasma membrane vesicles. J Cell Physiol 1982; 111: 213–217.CrossRefGoogle ScholarPubMed
32.Poste, G, Reeve, P.Inhibition of virus-induced cell fusion by local anaesthetics and phenothiazine tranquillizers. J Gen Virol 1972: 16: 21–28.CrossRefGoogle Scholar
33.Connor, CG, Brady, RC, Brownstein, BL.Trifluoperazine inhibits spreading and migration of cells in culture. J Cell Physiol 1981: 108: 299–307.CrossRefGoogle ScholarPubMed
34.Horwitz, SB, Chia, GH, Harracksingh, Cet al. Trifluoperazine inhibits phagocytosis in a macrophage-like cultured cell line. J Cell Biol 1981;91: 798–802.CrossRefGoogle Scholar
35.Moskowitz, N, Shapiro, L, Schook, Wet al. Phospholipase A2 modulation by calmodulin, prostaglandins and cyclic nucleotides. Biochem Biophys Res Comm 1983; 115: 94–99.CrossRefGoogle ScholarPubMed
36.Flower, RJ, Blackwell, GJ.The importance of phospholipase - A2 in prostaglandin biosynthesis. Biochem Pharmacol 1976; 25: 285–291.CrossRefGoogle ScholarPubMed
37.Whorton, AR, Willis, CE, Kent, RSet al. The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells. Lipids 1984; 19: 17–24.CrossRefGoogle ScholarPubMed
38.Zink, HA, Podos, SM, Becker, B.Inhibition by imidazole of the increase in intraocular pressure induced by topical prostaglandin E. Nature (New Biol) 1973; 245: 21–22.CrossRefGoogle ScholarPubMed
39.Zink, HA, Podos, SM.Becker, B.Modification by imidazoles of ocular inflammatory and pressure responses. Invest Ophthalmol 1975; 14: 280–285.Google ScholarPubMed
40.Peskar, BA, Glatt, M, Anhut, Het al. Effect of imidazole on prostaglandin and thromboxane accumulation in urate arthritis. Eur J Pharmacol 1978; 50: 437–441.CrossRefGoogle ScholarPubMed
41.Goodman, HM.Metabolic effects of imidazole in adipose tissue. Biochim Biophys Acta 1969; 176: 60–64.CrossRefGoogle ScholarPubMed
42.Westergaard, E.The effect of serotonin, norepinephrine and cyclic AMPon the blood-brain barrier. J Ultrastruct Res 1975:50: 383.Google Scholar
43.Joo, FZ, Rakonczay, Z.Wolleman, M.cAMP-mediated regulation of the permeability in the brain capillaries. Experientia 1975; 31 : 582–584.CrossRefGoogle ScholarPubMed
44.Bareis, DL, Manganiello, VC, Hirata, Fet al. Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts. Proc Natl Acad Sci USA 1983; 80: 2514–2518.CrossRefGoogle ScholarPubMed
45.Bundgaard, M.Vesicular transport in capillary endothelium: does it occur? Federation Proc 1983; 42: 2425–2430.Google ScholarPubMed
46.Huttner, I, Boutet, M, Rona, Get al. Studies on protein passage through arterial endothelium. Ill Effect of blood pressure levels on the passage of fine structural protein tracers through rat arterial endothelium. Lab Invest 1973: 29: 536–546.Google Scholar
47.Barnes, CD.Drug dosage in laboratory animals, a handbook. Berkley: University of California Press 1973.Google Scholar